✦ LIBER ✦

Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 study

✍ Scribed by Hagop Kantarjian; Stefan Faderl; Guillermo Garcia-Manero; Selina Luger; Parameswaran Venugopal; Lori Maness; Meir Wetzler; Steven Coutre; Wendy Stock; David Claxton; Stuart L Goldberg; Martha Arellano; Stephen A Strickland; Karen Seiter; Gary Schiller; Elias Jabbour; Judy Chiao; William Plunkett

Book ID: 119609063
Publisher: The Lancet
Year: 2012
Tongue: English
Weight: 186 KB
Volume: 13
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(12)70436-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Two dosing regimens of tosedostat in eld

Two dosing regimens of tosedostat in elderly patients with relapsed or refractory acute myeloid leukaemia (OPAL): a randomised open-label phase 2 study

✍ Cortes, Jorge; Feldman, Eric; Yee, Karen; Rizzieri, David; Advani, Anjali S; Cha 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 261 KB

Oral idarubicin in the treatment of acut

Oral idarubicin in the treatment of acute myelogenous leukaemia and the blast phase of chronic myeloid leukaemia

✍ S. T. A. Malik; J. Tucker; A. Z. S. Rohatiner; W. Brace; T. A. Lister 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB

Fourteen patients with poor-risk acute myelogenous leukaemia (AML) and five patients with accelerated phase/blast crisis chronic myeloid leukaemia (CML) were treated with 3 days of oral idarubicin (25 mg/m2/ day). No complete remissions or return to chronic phase CML were observed. A fall in the per

Oral administration of arsenic trioxide

Oral administration of arsenic trioxide in the treatment of acute promyelocytic leukaemia and accelerated phase chronic myeloid leukaemia: an Australian single-centre study

✍ F. Firkin 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 281 KB

Oral treatment of acute myeloid leukaemi

Oral treatment of acute myeloid leukaemia with etoposide, thioguanine, and idarubicin (ETI) in elderly patients: a prospective randomised comparison with intravenous cytarabine, idarubicin, and thioguanine in the second and third treatment cycle

✍ T. Ruutu; E. Koivunen; T. Nousiainen; T.-T. Pelliniemi; A. Almqvist; P. Anttila; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

The use of an all oral chemotherapy (ida

The use of an all oral chemotherapy (idarubicin and etoposide) in the treatment of acute myeloid leukaemia in the elderly: a report of toxicity and efficacy

✍ Jackson, G H; Taylor, P R A; Iqbal, A; Galloway, M J; Turner, G; Haynes, A; Hami 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 197 KB

Effect of gemtuzumab ozogamicin on survi

Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study

✍ Sylvie Castaigne; Cécile Pautas; Christine Terré; Emmanuel Raffoux; Dominique Bo 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 287 KB